Geopolitics & Trade

As account takeover attacks surge, Accertify's new AI-driven 'Attack State' aims to shift defenses from reactive to proactive, securing the login itself.

Oaktree Capital will acquire a controlling stake in Atlantic Coast Life, providing a critical lifeline to A-CAP's financially troubled insurance units.

SnoFox Sciences rebrands as FieldTech and joins a national network, merging its data platform with hands-on service for a new era of industrial reliability.

The CLO-focused fund is raising fresh capital amid financial pressures, offering income investors a high yield while navigating a complex credit market.

An independent author with a background in fiction writing offers a new, multidisciplinary lens on the Middle East, aiming to move beyond the headlines.

Advocates and doctors urge lowering the colorectal cancer screening age to 45 as rates soar in young adults, sparking a debate on policy and resources.

Institutional Investor launches an allocator-curated 'Buy List' to benchmark private equity excellence, prioritizing transparency and governance over marketing.

Emerald Holding reports a 16% revenue jump but a $30.7M net loss, driven by acquisition costs, as the board considers a potential company sale.

As the Federal Reserve's hawkish signals roil precious metals, a new report urges disciplined strategies. But is platform education enough for investors?

The healthcare REIT's significant dividend increase is backed by a record year of investment, a strong balance sheet, and strategic expansion into new markets.

The engineering giant renews its massive share buyback plan, signaling deep confidence in its stock amid a nuclear boom and a unique pact with La Caisse.

SpaceX acquires a key composite tech supplier from Hexagon Purus, a deal that fuels its Starship ambitions and lets the energy firm focus on its core mission.

With a key regulatory approval, fintech firm QuantPower brings institutional-grade automated trading to everyday investors, signaling a shift in India's market.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

The Joint Corp. posts higher profits through a major franchise pivot, but declining patient visits and sales raise questions about its long-term health.

As FGI Industries prepares its 2025 results, investors watch for clues on the health of the home improvement sector amid economic uncertainty.

A coalition of 20 organizations has petitioned the state to ban lead ammunition, citing overwhelming evidence of harm to eagles, wildlife, and humans.

With mega-events looming, West Hollywood launches an AI-powered tourism platform to capture a global audience. But can technology preserve its unique character?